Keyword: COVID-19


Pfizer Files Rebuttal of Moderna’s Patent Claim

08.12.2022 -

Faced with a lawsuit from US rival Moderna, alleging that Pfizer and its German partner BioNTech infringed one of its patent for their top-selling Covid-19 vaccine...


AstraZeneca Sells US Site to National Resilience

07.12.2022 -

Two weeks after annnouncing that it would no longer seek to market its Covid-19 vaccine in the US, Anglo-Swedish drugmaker AstraZeneca has unveiled plans to sell its...


AstraZeneca Withdraws US Vaxzevria Launch Plan

16.11.2022 -

AstraZeneca (AZ) has announced it is permanently backing away from any plans to sell its Vaxzevria-branded Covid-19 vaccine in the US.


BioNTech Buys Novartis Singapore Plant for Asia HQ

15.11.2022 -

German Covid-19 vaccine specialist BioNTech has acquired a production facility in Singapore from Swiss drugmaker Novartis that will serve as a manufacturing base in...


EU Approves Sanofi/GSK Covid Booster

11.11.2022 -

After several delays and restarts and a lengthy review by the European Medicines Agency (EMA), the Covid-19 vaccine called VidPrevtyn Beta developed by the French-British...


Pfizer/BioNTech Bivalent Covid Booster Wins Approvals

10.11.2022 -

UK health regulator Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech bivalent Covid-19 vaccine for use as a booster in people...


Omicron-targeted Covid Boosters may not be Better

28.10.2022 -

The newly launched bivalent mRNA-based Covid-19 booster shots from Moderna and Pfizer/BioNTech did not show a major improvement over the companies’ first-generation...


Trinseo Mulls Multiple Plant Closures

24.10.2022 -

In response to what it describes as a “challenging macroeconomic environment” marked by continuing erosion of consumer sentiment in Europe and the lack of any meaningful...